Position in SVRA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$459,202
New position
Shares Held
84,103
first reported quarter
Ownership
0.041%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#83
of 184 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Optimize Financial Inc holds $10,772,429 across 24 Biotechnology names. SVRA ranks #6 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KOD |
Kodiak Sciences Inc.
|
17,828 | $679,603 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
13,442 | $659,330 | |
| 3 | ELVN |
Enliven Therapeutics, Inc.
|
15,055 | $590,156 | |
| 4 | BCAX |
Bicara Therapeutics Inc.
|
23,996 | $477,280 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
2,730 | $461,424 | |
| 6 | SVRA |
Savara Inc
This page
|
84,103 | $459,202 | |
| 7 | RAPP |
Rapport Therapeutics, Inc.
|
14,656 | $458,586 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,381 | $456,931 |
All Filings in SVRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $459,202 | 84,103 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||